AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32808888 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 27
Study 32808888 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 27
Study 36468509 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive mesh (S group)
Number of subjects: 100
Study 36468509 — intervention group
Group type: COMPARATOR
Intervention: Conventional polypropylene mesh (P group)
Number of subjects: 100
Study 34607077 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session of physiotherapy and self-management (ARTISAN intervention)
Number of subjects: 0
Study 34607077 — intervention group
Group type: COMPARATOR
Intervention: Usual care physiotherapy
Number of subjects: 0
Study 33124791 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins (10 mg of rosuvastatin)
Number of subjects: 83
Study 33124791 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo + Exercise Training (PLET)
Number of subjects: 83
Study 33124791 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins + Exercise Training (STAET)
Number of subjects: 83
Study 33124791 — intervention group
Group type: COMPARATOR
Intervention: Statins (STA)
Number of subjects: 83
Study 33124791 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 83
Study 35697491 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular-based training workout, 5 times per week for 10 weeks, 20 to 30 minutes per session
Number of subjects: 22
Study 35697491 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 22
Study 35697491 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular-based training workout
Number of subjects: 22
Study 32972483 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for psychosis (CBTp) using a novel tabletised manual
Number of subjects: 24
Study 33080100 — intervention group
Group type: EXPERIMENTAL
Intervention: cetuximab + M (one-arm design)
Number of subjects: 135
Study 33080100 — intervention group
Group type: COMPARATOR
Intervention: cetuximab (two-arm design)
Number of subjects: 135
Study 33080100 — intervention group
Group type: EXPERIMENTAL
Intervention: cetuximab + M (two-arm design)
Number of subjects: 135
Study 33080100 — intervention group
Group type: COMPARATOR
Intervention: cetuximab (four-arm design)
Number of subjects: 135
Study 33080100 — intervention group
Group type: EXPERIMENTAL
Intervention: cetuximab + M (four-arm design)
Number of subjects: 135
Study 35209775 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS)
Number of subjects: 25198
Study 35209775 — intervention group
Group type: EXPERIMENTAL
Intervention: CDS plus Shared Decision Making (CDS+SDM)
Number of subjects: 25198
Study 35209775 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 25198
Study 32845399 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent suture (Gore‐Tex)
Number of subjects: 200
Study 32845399 — intervention group
Group type: COMPARATOR
Intervention: Absorbable suture (PDS)
Number of subjects: 200
Study 32845399 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Gore‐Tex and PDS)
Number of subjects: 200
Study 32305186 — intervention group
Group type: COMPARATOR
Intervention: Multiple arterial graft (MAG) group (2 or more arterial grafts with additional saphenous veins)
Number of subjects: 2484
Study 32305186 — intervention group
Group type: COMPARATOR
Intervention: Total arterial graft (TAG) group (3 or more arterial grafts only)
Number of subjects: 2484
Study 33257297 — intervention group
Group type: EXPERIMENTAL
Intervention: Video plus mental training group
Number of subjects: 24
Study 35585570 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of conbercept (IVC) 3 days before PPV
Number of subjects: 34
Study 35585570 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal injection of conbercept (IVC) after PPV
Number of subjects: 34
Study 35585570 — intervention group
Group type: COMPARATOR
Intervention: Aqueous humor from age-matched cataract patients (control group)
Number of subjects: 34
Study 35585570 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-bleeding (INB) group
Number of subjects: 34
Study 35585570 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative bleeding (IOB) group
Number of subjects: 34
Study 33128790 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE‐TeL programme (12-week intervention including comprehensive oral and physical exercises and textured lunch gatherings)
Number of subjects: 86
Study 33128790 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise regimen only (control group)
Number of subjects: 86
Study 35306161 — intervention group
Group type: COMPARATOR
Intervention: Spinal Anesthesia (Control)
Number of subjects: 152
Study 34267185 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose vaccine
Number of subjects: 1128
Study 34267185 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose vaccine
Number of subjects: 1128
Study 34267185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1128
Study 32521054 — intervention group
Group type: EXPERIMENTAL
Intervention: Shikani optical stylet (SOS)
Number of subjects: 50
Study 32521054 — intervention group
Group type: COMPARATOR
Intervention: fiberoptic bronchoscope (FOB)
Number of subjects: 50
Study 33024237 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone (25 mg/day)
Number of subjects: 141
Study 33024237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 35100493 — intervention group
Group type: EXPERIMENTAL
Intervention: LC hair essence serum injection (1 ml diluted with 0.5 ml of 0.9% normal saline, once weekly for 8 weeks)
Number of subjects: 62
Study 35100493 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin-A injection (50 units)
Number of subjects: 62
Study 33279467 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT with CF (telehealth)
Number of subjects: 28
Study 33279467 — intervention group
Group type: COMPARATOR
Intervention: ACT with CF (in-person)
Number of subjects: 28
Study 33514393 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-assisted ankle robot (PAAR)
Number of subjects: 47
Study 33514393 — intervention group
Group type: EXPERIMENTAL
Intervention: Swing-controlled ankle robot (SCAR)
Number of subjects: 47
Study 33514393 — intervention group
Group type: COMPARATOR
Intervention: Conventional training (CT)
Number of subjects: 47
Study 32648771 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA)
Number of subjects: 1701
Study 35076685 — intervention group
Group type: EXPERIMENTAL
Intervention: Device closure of patent foramen ovale
Number of subjects: 0
Study 35076685 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34281754 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshops‐Only
Number of subjects: 184
Study 34281754 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshops + SMS/texting
Number of subjects: 184
Study 34281754 — intervention group
Group type: COMPARATOR
Intervention: No‐Intervention‐Control
Number of subjects: 184
Study 33238829 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative stent
Number of subjects: 283
Study 33238829 — intervention group
Group type: COMPARATOR
Intervention: Nonintraoperative stent
Number of subjects: 283
Study 33238829 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative stent with ileal conduit
Number of subjects: 283
Study 36042439 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (PN) commenced on day 1 or day 2 of admission
Number of subjects: 60
Study 36042439 — intervention group
Group type: COMPARATOR
Intervention: Late parenteral nutrition (PN) commenced on day 6 of admission
Number of subjects: 60
Study 36042439 — intervention group
Group type: EXPERIMENTAL
Intervention: Early PN
Number of subjects: 60
Study 36042439 — intervention group
Group type: COMPARATOR
Intervention: Late PN
Number of subjects: 60
Study 33960081 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron 100 mg/day for 8 weeks
Number of subjects: 70
Study 33960081 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 70
Study 32067381 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% dexamethasone nanoparticle (DexNP) eye drops postoperatively
Number of subjects: 20
Study 32067381 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC) and Maxidex® eye drops postoperatively
Number of subjects: 20
Study 32067381 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 33481863 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum mothers with family monthly income <150 USD
Number of subjects: 415
Study 33481863 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum mothers whose husbands had migrated for employment
Number of subjects: 415
Study 33481863 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum mothers with nearest health facility located at more than 60 minutes walking distance
Number of subjects: 415
Study 33481863 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum mothers who delivered their last child by cesarean section
Number of subjects: 415
Study 33481863 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum mothers who received less than four recommended antenatal care visits
Number of subjects: 415
Study 33481863 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum mothers who had planned pregnancy
Number of subjects: 415
Study 32066784 — intervention group
Group type: EXPERIMENTAL
Intervention: FLG loss-of-function (LOF) variants
Number of subjects: 386
Study 32066784 — intervention group
Group type: EXPERIMENTAL
Intervention: Two or more FLG LOF variants
Number of subjects: 386
Study 32066784 — intervention group
Group type: EXPERIMENTAL
Intervention: All detected FLG LOF variants
Number of subjects: 386
Study 32066784 — intervention group
Group type: COMPARATOR
Intervention: Rare variants in the EDC region
Number of subjects: 386
Study 36260577 — intervention group
Group type: EXPERIMENTAL
Intervention: Exoskeleton-assisted walking (EAW)
Number of subjects: 40
Study 36260577 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise program
Number of subjects: 40
Study 34280529 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticospinal tract (CST) microstructure analysis using fractional anisotropy and mean diffusivity
Number of subjects: 199
Study 34280529 — intervention group
Group type: EXPERIMENTAL
Intervention: Circle drawing task (dexterity measure)
Number of subjects: 199
Study 34280529 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression analyses
Number of subjects: 199
Study 34280529 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian regression analysis
Number of subjects: 199
Study 32948138 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Criteria Group (fasting plasma glucose < 5.1 mmol/L, AND 1 hour < 10.0 mmol/L, AND 2 hour < 8.5 mmol/L)
Number of subjects: 4158
Study 32948138 — intervention group
Group type: COMPARATOR
Intervention: Higher Criteria Group (fasting plasma glucose < 5.5 mmol/L, AND 2 hour < 9.0 mmol/L)
Number of subjects: 4158
Study 32948138 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Criteria Group
Number of subjects: 4158
Study 32948138 — intervention group
Group type: COMPARATOR
Intervention: Higher Criteria Group
Number of subjects: 4158
Study 35644623 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation (LKM) training for 8 weeks
Number of subjects: 100
Study 35644623 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 33677737 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP‐VR
Number of subjects: 40
Study 33677737 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertiguard‐VR
Number of subjects: 40
Study 33677737 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 40
Study 32444327 — intervention group
Group type: EXPERIMENTAL
Intervention: Epalrestat
Number of subjects: 120
Study 32444327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 35000838 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA + Sucrose + RB + Music
Number of subjects: 103
Study 35000838 — intervention group
Group type: COMPARATOR
Intervention: EMLA + Sucrose + RB
Number of subjects: 103
Study 34130017 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid digesting carbohydrate (RDC)
Number of subjects: 19
Study 34130017 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow digesting carbohydrate (SDC)
Number of subjects: 19
Study 35045272 — intervention group
Group type: EXPERIMENTAL
Intervention: Male-predominant plasma
Number of subjects: 0
Study 35045272 — intervention group
Group type: COMPARATOR
Intervention: Plasma from multiparous donors
Number of subjects: 0
Study 35045272 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus panel definitions (TRALI type I and TRALI type II)
Number of subjects: 0
Study 35045272 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical expertise in critical care or pulmonary medicine
Number of subjects: 0
Study 32669051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1RMMVT (minimal velocity threshold)
Number of subjects: 20
Study 32669051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1RMLD0 (load at zero velocity)
Number of subjects: 20
Study 32669051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1RMFV (force-velocity)
Number of subjects: 20
Study 32669051 — intervention group
Group type: COMPARATOR
Intervention: Free-weight exercises
Number of subjects: 20
Study 32669051 — intervention group
Group type: COMPARATOR
Intervention: 7-load predictions
Number of subjects: 20
Study 32669051 — intervention group
Group type: EXPERIMENTAL
Intervention: 1RMMVT
Number of subjects: 20
Study 32669051 — intervention group
Group type: EXPERIMENTAL
Intervention: Smith machine exercises
Number of subjects: 20
Study 32669051 — intervention group
Group type: COMPARATOR
Intervention: Free-weight squat and overhead press predictions
Number of subjects: 20
Study 34355250 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP 980 (6 mg/kg) plus pertuzumab (420 mg)
Number of subjects: 36
Study 34355250 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab RP (6 mg/kg) plus pertuzumab (420 mg)
Number of subjects: 36
Study 32645830 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Foot Exercise (SFE) training
Number of subjects: 85
Study 32645830 — intervention group
Group type: COMPARATOR
Intervention: Non-Biomechanical Function (NBF) exercise
Number of subjects: 85
Study 35073366 — intervention group
Group type: EXPERIMENTAL
Intervention: FES row training (FESRT)
Number of subjects: 31
Study 35073366 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 31
Study 33325403 — intervention group
Group type: EXPERIMENTAL
Intervention: LUS guided RM
Number of subjects: 44
Study 33325403 — intervention group
Group type: COMPARATOR
Intervention: Non-ultrasound guided RM
Number of subjects: 44
Study 35306390 — intervention group
Group type: EXPERIMENTAL
Intervention: DAA treatment with BDI-II scores ≥ 18 at baseline
Number of subjects: 150
Study 35306390 — intervention group
Group type: COMPARATOR
Intervention: DAA treatment with BDI-II scores < 18 at baseline
Number of subjects: 150
Study 34457094 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led care (patient education and phone calls)
Number of subjects: 108
Study 34457094 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 108
Study 34457094 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led care
Number of subjects: 108
Study 32936233 — intervention group
Group type: EXPERIMENTAL
Intervention: Worst Itch Numeric Rating Scale (WI‐NRS)
Number of subjects: 123
Study 32936233 — intervention group
Group type: EXPERIMENTAL
Intervention: Average Itch Numeric Rating Scale (AI‐NRS)
Number of subjects: 123
Study 32936233 — intervention group
Group type: EXPERIMENTAL
Intervention: Itch Numeric Rating Scale (NRS) items
Number of subjects: 123
Study 32936233 — intervention group
Group type: EXPERIMENTAL
Intervention: Worst Itch Visual Analog Scale (WI‐VAS)
Number of subjects: 123
Study 32936233 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Verbal Rating Scale (eVRS) for itch severity
Number of subjects: 123
Study 32553498 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive Elastic Method (PROEL)
Number of subjects: 15
Study 32553498 — intervention group
Group type: COMPARATOR
Intervention: Standard perioperative rehabilitation
Number of subjects: 15
Study 32487263 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein-based protocol (CRP)
Number of subjects: 130
Study 32487263 — intervention group
Group type: COMPARATOR
Intervention: Best practices for rational use of antibiotics (Control)
Number of subjects: 130
Study 35044504 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Lycium barbarum (20 g, containing 20 mg of zeaxanthin and 2 mg of lutein)
Number of subjects: 54
Study 35044504 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Lycium barbarum (10 g, containing 10 mg of zeaxanthin and 1 mg of lutein)
Number of subjects: 54
Study 35044504 — intervention group
Group type: COMPARATOR
Intervention: Low-dose control (1 mg of lutein)
Number of subjects: 54
Study 35044504 — intervention group
Group type: COMPARATOR
Intervention: High-dose control (2 mg of lutein)
Number of subjects: 54
Study 35044504 — intervention group
Group type: COMPARATOR
Intervention: Blank control
Number of subjects: 54
Study 33905971 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological Momentary Assessment (EMA) adherence
Number of subjects: 110
Study 34049283 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific template-guided (TG) pedicle screw insertion
Number of subjects: 24
Study 34049283 — intervention group
Group type: COMPARATOR
Intervention: Standard freehand (FH) pedicle screw insertion
Number of subjects: 24
Study 35085177 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase change material liners
Number of subjects: 42
Study 35085177 — intervention group
Group type: COMPARATOR
Intervention: Conventional liners
Number of subjects: 42
Study 33128725 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing Spondylitis Quality of Life (ASQoL) scale
Number of subjects: 325
Study 33128725 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric assessment methods (exploratory factor analysis, item response theory)
Number of subjects: 325
Study 32202814 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive‐expressive (SE) psychodynamic treatment
Number of subjects: 1
Study 32202814 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed clinical model for resolution of alliance ruptures
Number of subjects: 1
Study 32308012 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-Plan
Number of subjects: 358
Study 34503565 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Tianshu (ST25)
Number of subjects: 105
Study 34503565 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zusanli (ST36)
Number of subjects: 105
Study 34503565 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electroacupuncture)
Number of subjects: 105
Study 35062752 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard three-dose (SD) Hepatitis B vaccine
Number of subjects: 61
Study 35062752 — intervention group
Group type: EXPERIMENTAL
Intervention: Double three-dose (DD) Hepatitis B vaccine
Number of subjects: 61
Study 35062752 — intervention group
Group type: COMPARATOR
Intervention: Both SD and DD
Number of subjects: 61
Study 33784233 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher CI‐6MW
Number of subjects: 477
Study 33784233 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 477
Study 36194605 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD participants (study group)
Number of subjects: 138
Study 36194605 — intervention group
Group type: COMPARATOR
Intervention: Older adults without respiratory conditions (control group)
Number of subjects: 138
Study 33618392 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric biceps exercise (4×1 min at 30% of 1‐RM, 2 min recovery)
Number of subjects: 12
Study 33618392 — intervention group
Group type: COMPARATOR
Intervention: Control session (without exercise)
Number of subjects: 12
Study 32827348 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 20-60 mg/day
Number of subjects: 525
Study 32827348 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 80-120 mg/day
Number of subjects: 525
Study 32827348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 525
Study 34331755 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manual therapy (OMT)
Number of subjects: 68
Study 34331755 — intervention group
Group type: COMPARATOR
Intervention: Kaltenborn-Evjenth orthopedic manual therapy (KEOMT)
Number of subjects: 68
Study 34420366 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI (n=388)
Number of subjects: 1171
Study 34420366 — intervention group
Group type: COMPARATOR
Intervention: No PCI (n=198)
Number of subjects: 1171
Study 34373566 — intervention group
Group type: EXPERIMENTAL
Intervention: TroponinT levels at admission
Number of subjects: 105
Study 32443329 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP-SMX plus azithromycin
Number of subjects: 200
Study 32443329 — intervention group
Group type: COMPARATOR
Intervention: Synergistic sulfonamides plus clindamycin
Number of subjects: 200
Study 32443329 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 34991746 — intervention group
Group type: EXPERIMENTAL
Intervention: Provox XtraFlow
Number of subjects: 28
Study 34991746 — intervention group
Group type: EXPERIMENTAL
Intervention: Provox Luna
Number of subjects: 28
Study 34078289 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength intervention group
Number of subjects: 0
Study 34078289 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance intervention group
Number of subjects: 0
Study 34078289 — intervention group
Group type: COMPARATOR
Intervention: Control group (no regular exercise)
Number of subjects: 0
Study 32193889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-CT index (AUC, 0.81)
Number of subjects: 2218
Study 32193889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-CT index cutoff ≥ 46
Number of subjects: 2218
Study 32193889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-CT index cutoff ≥ 56.5
Number of subjects: 2218